{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:46:24Z","timestamp":1791827184968,"version":"4.3.4"},"reference-count":74,"publisher":"Xia & He Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,28]]},"DOI":"10.14218\/jcth.2017.00067","type":"journal-article","created":{"date-parts":[[2017,12,17]],"date-time":"2017-12-17T20:43:57Z","timestamp":1513543437000},"page":"1-6","source":"Crossref","is-referenced-by-count":154,"title":["Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review"],"prefix":"10.14218","volume":"6","author":[{"given":"Page","family":"Axley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunirah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2017,12,17]]},"reference":[{"key":"key20171217204351_b1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/hep.21826","article-title":"Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study","volume":"46","author":"Bruno","year":"2007","journal-title":"Hepatology"},{"key":"key20171217204351_b2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016","volume":"66","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"key20171217204351_b3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review","volume":"312","author":"Kohli","year":"2014","journal-title":"JAMA"},{"key":"key20171217204351_b4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20171217204351_b5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"key":"key20171217204351_b6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"key20171217204351_b7","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key20171217204351_b8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","journal-title":"Lancet"},{"key":"key20171217204351_b9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: A global view","volume":"7","author":"Yang","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20171217204351_b10","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20171217204351_b11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.gastro.2006.01.032","article-title":"Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality","volume":"130","author":"Tanaka","year":"2006","journal-title":"Gastroenterology"},{"key":"key20171217204351_b12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","article-title":"A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt","volume":"31","author":"Sievert","year":"2011","journal-title":"Liver Int"},{"key":"key20171217204351_b13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ajg.2014.11","article-title":"Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States","volume":"109","author":"Altekruse","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key20171217204351_b14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"key20171217204351_b15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2015.09.006","article-title":"Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival","volume":"64","author":"Yan","year":"2016","journal-title":"J Hepatol"},{"key":"key20171217204351_b16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ajg.2014.214","article-title":"Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans","volume":"109","author":"El-Serag","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key20171217204351_b17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013","volume":"149","author":"Beste","year":"2015","journal-title":"Gastroenterology"},{"key":"key20171217204351_b18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2010.01.033","article-title":"Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study","volume":"53","author":"Omland","year":"2010","journal-title":"J Hepatol"},{"key":"key20171217204351_b19","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/hep.27337","article-title":"Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients","volume":"60","author":"Kruse","year":"2014","journal-title":"Hepatology"},{"key":"key20171217204351_b20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0000000000000494","article-title":"The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection","volume":"68","author":"Kramer","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171217204351_b21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.25800","article-title":"The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection","volume":"57","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"key":"key20171217204351_b22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/cid\/ciw380","article-title":"Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus-coinfected individuals from 2001 to 2014: a multicohort study","volume":"63","author":"Gj\u00e6rde","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key20171217204351_b23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","article-title":"HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV","volume":"60","author":"Kanwal","year":"2014","journal-title":"Hepatology"},{"key":"key20171217204351_b24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ajg.2017.123","article-title":"HCV genotype 6 increased the risk for hepatocellular carcinoma among asian patients with liver cirrhosis","volume":"112","author":"Lee","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key20171217204351_b25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1055-9965.EPI-09-1297","article-title":"Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis","volume":"19","author":"Chuang","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20171217204351_b26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"Am J Epidemiol"},{"key":"key20171217204351_b27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11901-017-0343-0","article-title":"Alcohol consumption in concomitant liver disease: how much is too much?","volume":"16","author":"Hagstr\u00f6m","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"key20171217204351_b28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MCG.0b013e3180381584","article-title":"Mechanisms of synergy between alcohol and hepatitis C virus","volume":"41","author":"Singal","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"key20171217204351_b29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6603891","article-title":"Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan","volume":"97","author":"Wakai","year":"2007","journal-title":"Br J Cancer"},{"key":"key20171217204351_b30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/liv.12304","article-title":"Impact of coffee on liver diseases: a systematic review","volume":"34","author":"Saab","year":"2014","journal-title":"Liver Int"},{"key":"key20171217204351_b31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jgh.13670","article-title":"Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study","volume":"32","author":"Huang","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171217204351_b32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14218\/JCTH.2015.00001","article-title":"Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases","volume":"3","author":"Raff","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"key20171217204351_b33","doi-asserted-by":"crossref","first-page":"e6508","DOI":"10.1097\/MD.0000000000006508","article-title":"Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-na\u00efve chronic hepatitis C patients in China","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"key20171217204351_b34","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"key20171217204351_b35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/apt.14273","article-title":"The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease","volume":"46","author":"Rao","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171217204351_b36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cmi.2016.07.019","article-title":"Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma","volume":"22","author":"Vescovo","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key20171217204351_b37","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1096\/fj.06-7345com","article-title":"Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity","volume":"21","author":"Li","year":"2007","journal-title":"FASEB J"},{"key":"key20171217204351_b38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/gast.2002.30983","article-title":"Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein","volume":"122","author":"Okuda","year":"2002","journal-title":"Gastroenterology"},{"key":"key20171217204351_b39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1053\/j.gastro.2012.01.045","article-title":"Is hepatitis C virus carcinogenic?","volume":"142","author":"Lemon","year":"2012","journal-title":"Gastroenterology"},{"key":"key20171217204351_b40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.gastro.2005.03.089","article-title":"Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells","volume":"129","author":"Schulze-Krebs","year":"2005","journal-title":"Gastroenterology"},{"key":"key20171217204351_b41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molcel.2012.07.032","article-title":"Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production","volume":"48","author":"Yu","year":"2012","journal-title":"Mol Cell"},{"key":"key20171217204351_b42","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.aaf9011","article-title":"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention","volume":"355","author":"Tomasetti","year":"2017","journal-title":"Science"},{"key":"key20171217204351_b43","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"Nault","year":"2014","journal-title":"Hepatology"},{"key":"key20171217204351_b44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"key":"key20171217204351_b45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cgh.2009.10.026","article-title":"Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20171217204351_b46","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.13633","article-title":"Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis","volume":"43","author":"Majumdar","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171217204351_b47","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29408","article-title":"Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease","author":"Backus","year":"2017","journal-title":"Hepatology"},{"key":"key20171217204351_b48","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"key20171217204351_b49","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2016.07.029","article-title":"Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?","volume":"65","author":"Zeng","year":"2016","journal-title":"J Hepatol"},{"key":"key20171217204351_b50","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J Hepatol"},{"key":"key20171217204351_b51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","author":"Ioannou","year":"2017","journal-title":"J Hepatol"},{"key":"key20171217204351_b52","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/jvh.12726","article-title":"The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience","volume":"24","author":"Bielen","year":"2017","journal-title":"J Viral Hepat"},{"key":"key20171217204351_b53","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.gastro.2016.12.021","article-title":"Unusually high rates of hepatocellular carcinoma after treatment with direct-acting antiviral therapy for hepatitis C related cirrhosis","volume":"152","author":"Ravi","year":"2017","journal-title":"Gastroenterology"},{"key":"key20171217204351_b54","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1007\/s10620-017-4739-z","article-title":"Direct-acting antivirals decreased tumor recurrence after initial treatment of hepatitis C virus-related hepatocellular carcinoma","volume":"62","author":"Ikeda","year":"2017","journal-title":"Dig Dis Sci"},{"key":"key20171217204351_b55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2016.07.043","article-title":"The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma","volume":"65","author":"Minami","year":"2016","journal-title":"J Hepatol"},{"key":"key20171217204351_b56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/apt.13821","article-title":"Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171217204351_b57","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J Hepatol"},{"key":"key20171217204351_b58","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2016.06.023","article-title":"Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma","volume":"65","author":"Yang","year":"2016","journal-title":"J Hepatol"},{"key":"key20171217204351_b59","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jhep.2017.01.020","article-title":"Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals","volume":"66","author":"Prenner","year":"2017","journal-title":"J Hepatol"},{"key":"key20171217204351_b60","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/lt.24790","article-title":"Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals","volume":"23","author":"Zanetto","year":"2017","journal-title":"Liver Transpl"},{"key":"key20171217204351_b61","first-page":"421","article-title":"Occurrence and recurrence of hepatocellular carcinoma after successful direct-acting antiviral therapy for patients with chronic hepatitis C virus infection","volume":"13","author":"Grandhe","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key20171217204351_b62","first-page":"47","article-title":"Recommendations for the treatment of hepatitis C in 2017","volume":"3","author":"Polish Group of Experts for","year":"2017","journal-title":"Clin Exp Hepatol"},{"key":"key20171217204351_b63","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00432-014-1806-0","article-title":"Management of hepatocellular carcinoma","volume":"141","author":"Fitzmorris","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20171217204351_b64","first-page":"38","article-title":"Surveillance and diagnosis of hepatocellular carcinoma","volume":"11","author":"Fitzmorris","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key20171217204351_b65","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"key20171217204351_b66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-642-16037-0_3","article-title":"Imaging of hepatocellular carcinoma: current concepts","volume":"190","author":"Parikh","year":"2013","journal-title":"Recent Results Cancer Res"},{"key":"key20171217204351_b67","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1053\/j.gastro.2004.09.023","article-title":"Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma","volume":"127","author":"Daniele","year":"2004","journal-title":"Gastroenterology"},{"key":"key20171217204351_b68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171217204351_b69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"key20171217204351_b70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"key20171217204351_b71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","article-title":"Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?","volume":"107","author":"Lee","year":"2014","journal-title":"Antiviral Res"},{"key":"key20171217204351_b72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/hepr.12331","article-title":"Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response","volume":"45","author":"Tachi","year":"2015","journal-title":"Hepatol Res"},{"key":"key20171217204351_b73","doi-asserted-by":"crossref","first-page":"e0133515","DOI":"10.1371\/journal.pone.0133515","article-title":"Predictive ability of laboratory indices for liver fibrosis in patients with chronic hepatitis C after the eradication of hepatitis C virus","volume":"10","author":"Tachi","year":"2015","journal-title":"PLoS One"},{"key":"key20171217204351_b74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/ArticleFullText.aspx?sid=2&jid=1&id=10.14218%2fJCTH.2017.00067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:58Z","timestamp":1783707418000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/ArticleFullText.aspx?sid=2&jid=1&id=10.14218%2fJCTH.2017.00067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,17]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,17]]},"published-print":{"date-parts":[[2018,3,28]]}},"alternative-id":["10.14218\/JCTH.2017.00067"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2017.00067","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,17]]}}}